Standardization and statistical approaches to therapeutic trials in the R6/2 mouse
- 23 July 2003
- journal article
- Published by Elsevier BV in Brain Research Bulletin
- Vol. 61 (5), 469-479
- https://doi.org/10.1016/s0361-9230(03)00185-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's DiseaseCell, 2000
- Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic miceHuman Molecular Genetics, 1999
- Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's diseasePhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouseHuman Molecular Genetics, 1999
- Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat LengthNeurobiology of Disease, 1998
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutationNature Genetics, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- More powerful procedures for multiple significance testingStatistics in Medicine, 1990
- EDF Statistics for Goodness of Fit and Some ComparisonsJournal of the American Statistical Association, 1974